"melanoma mortality" trang 4 - tải miễn phí từ tailieunhanh
Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: Case report and literature review

Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: Case report and literature review
5    34    1
The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: A phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale)

The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: A phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale)
8    72    1
Itraconazole treatment of primary malignant melanoma of the vagina evaluated using positron emission tomography and tissue cDNA microarray: A case report

Itraconazole treatment of primary malignant melanoma of the vagina evaluated using positron emission tomography and tissue cDNA microarray: A case report
6    63    1
Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: A case report

Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: A case report
7    84    1
Ablation of epidermal RXRα in cooperation with activated CDK4 and oncogenic NRAS generates spontaneous and acute neonatal UVB induced malignant metastatic melanomas

Ablation of epidermal RXRα in cooperation with activated CDK4 and oncogenic NRAS generates spontaneous and acute neonatal UVB induced malignant metastatic melanomas
13    52    1
MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1

MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1
12    77    1
Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma

Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma
9    46    1
The prognostic values of m6A RNA methylation regulators in uveal melanoma

The prognostic values of m6A RNA methylation regulators in uveal melanoma
13    59    1
Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell

Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell
11    83    1
Antiangiogenic agents targeting different angiogenic pathways have opposite effects on tumor hypoxia in R-18 human melanoma xenografts

Antiangiogenic agents targeting different angiogenic pathways have opposite effects on tumor hypoxia in R-18 human melanoma xenografts
7    41    1
Vemurafenib in Chinese patients with BRAFV600 mutation–positive unresectable or metastatic melanoma: An open-label, multicenter phase I study

Vemurafenib in Chinese patients with BRAFV600 mutation–positive unresectable or metastatic melanoma: An open-label, multicenter phase I study
7    60    1
Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies

Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies
7    60    1
Comparison of germline versus somatic BAP1 mutations for risk of metastasis in uveal melanoma

Comparison of germline versus somatic BAP1 mutations for risk of metastasis in uveal melanoma
12    64    1
Porcine circovirus type 2 ORF3 protein induces apoptosis in melanoma cells

Porcine circovirus type 2 ORF3 protein induces apoptosis in melanoma cells
12    44    1
Comparative efficacy and safety of combination therapies for advanced melanoma: A network meta-analysis

Comparative efficacy and safety of combination therapies for advanced melanoma: A network meta-analysis
10    49    1
Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: A model-based economic evaluation

Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: A model-based economic evaluation
11    72    1
Objective response to mTOR inhibition in a metastatic collision tumor of the liver composed of melanoma and adenocarcinoma with TSC1 loss: A case report

Objective response to mTOR inhibition in a metastatic collision tumor of the liver composed of melanoma and adenocarcinoma with TSC1 loss: A case report
5    35    1
Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
11    62    1
Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?

Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?
11    58    1
Tumour stage distribution and survival of malignant melanoma in Germany 2002–2011

Tumour stage distribution and survival of malignant melanoma in Germany 2002–2011
12    66    1